Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Diabetes Therapeutics Market Valued at Present and by 2029?

The market size for diabetes therapeutics has seen a swift expansion in recent years. The growth is projected to surge from $153.67 billion in 2024 to $170.06 billion in 2025, representing a Compound Annual Growth Rate (CAGR) of 10.7%. Several factors are contributing to this increase during the historic period, such as the initial rise in diabetes occurrence, extensive deployment of oral hypoglycemic medications, early incorporation of injectable insulin treatments, self-management awareness initiatives, and the introduction of biosimilar insulins to the market.

The market size for diabetes therapeutics is anticipated to experience expeditious expansion in the forthcoming years, reaching $252.95 billion by 2029 with a 10.4% compound annual growth rate (CAGR). Factors influencing this significant growth over the projected period include escalating digital literacy, greater acceptance of injectable non-insulin medicines, expansion of digital healthcare platforms, a surge in demand for personalized and combination treatments, as well as the enhancement of healthcare infrastructure and access to diabetes care. Key trends to observe during the forecast period involve automated insulin delivery (AID) systems, the application of artificial intelligence (AI) in diabetes management, device interoperability, utilisation of digital health applications, and the remote monitoring of patients.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25749&type=smp

#What Drivers Are Influencing Growth In The Diabetes Therapeutics Market?

The escalating rates of obesity are anticipated to fuel the expansion of the diabetes therapeutics market. Defined as an unhealthy accumulation of excessive fat, obesity is a significant risk element for type 2 diabetes. The upsurge in obesity rates is attributed to the growing consumption of high-calorie diets, with a larger portion of the populace eating sugar and fat-rich fast and processed foods. At the same time, physical activity levels are lowering, causing excessive weight gain. Diabetes therapeutics are beneficial in managing obesity as they enhance blood sugar control and assist in weight loss. They employ medications such as GLP-1 receptor agonists that diminish appetite and decelerate digestion, thus augmenting metabolic health in obese individuals. For example, a report released by the Office for Health Improvement and Disparities, a UK government department, in May 2024 indicated that roughly 64% of adults aged 18 and over were categorised as overweight or suffering from obesity in 2022 to 2023. This depicts an increase from the previous year’s statistic of 63.8%. As a result, the escalating rates of obesity are propelling the expansion of the diabetes therapeutics market.

What Are The Main Segments Identified In The Diabetes Therapeutics Market Research?

The diabetes therapeutics market covered in this report is segmented –

1) By Drug: Oral Anti-Diabetic Drugs, Insulin, Non-Insulin Injectable Drug, Combination Drug

2) By Type: Diabetes 1, Diabetes 2

3) By Route Of Administration: Oral, Subcutaneous, Intravenous

4) By Distribution Channel: Online Pharmacies, Hospital Pharmacies, Retail Pharmacies

5) By Application: Preventive, Treatment Or Care

Subsegments:

1) By Oral Anti-Diabetic Drugs: Biguanides, Sulfonylureas, DPP-4 Inhibitors, SGLT-2 Inhibitors, Thiazolidinediones, Meglitinides, Alpha-Glucosidase Inhibitors

2) By Insulin: Rapid-Acting Insulin, Short-Acting Insulin, Intermediate-Acting Insulin, Long-Acting Insulin, Premixed Insulin

3) By Non-Insulin Injectable Drug: GLP-1 Receptor Agonists, Amylin Analogs

4) By Combination Drug: Oral Combination Therapies, Oral and Injectable Combination Therapies

What Are The Leading Trends And Opportunities In The Diabetes Therapeutics Sector?

Leading corporations in the diabetes therapeutics market are placing emphasis on creating cutting-edge solutions like cognitive behavioral therapy (CBT) to augment personalized diabetes care and better manage blood sugar levels in type 2 diabetes patients. CBT is a structured, scientifically supported psychological treatment that enables individuals to recognize and adjust dysfunctional thought patterns and behaviors. In October 2023, the US-based digital therapeutics firm, Better Therapeutics Inc., introduced AspyreRx, a digital therapeutic app for diabetes. The FDA-authorized AspyreRx offers customized cognitive behavioral therapy (CBT) to individuals 18 years and older, encouraging behavioral modifications for better diabetes control. Originally known as BT-001, the clinical and statistical significance of AspyreRx in reducing A1c levels compared to standard treatment was demonstrated, along with enhanced blood pressure, weight, mood, and quality of life indicators in a randomized controlled trial.

Which Companies Play A Key Role In The Development Of The Diabetes Therapeutics Market?

Major companies operating in the diabetes therapeutics market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, Medtronic plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Biocon Biologics Limited, MannKind Corporation, Tandem Diabetes Care Inc., Lexicon Pharmaceuticals Inc., Better Therapeutics Inc., Adocia S.A., Oramed Pharmaceuticals Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/diabetes-therapeutics-global-market-report

What Are The Key Regional Developments Shaping The Diabetes Therapeutics Market?

North America was the largest region in the diabetes therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetes therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=25749&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model